Abstract:OBJECTIVE:The study was designed to compare the pharmacokinetic parameters and relative bioavailability of a newly generic acipimox 250-mg tablets (test formulation) with a branded 250-mg tablets (reference formulation).METHODS:A single-dose, randomized-sequence, 2-way crossover study was conducted in 20 healthy Chinese male volunteers in the fasted state. Plasma samples were collected over 12 h after a single oral dose of 250-mg acipimox test or reference, followed by a 7-day washout period. Plasma concentrations of acipimox were analyzed by high-performance liquid chromatography. Drug And Statistical-Version 2.0 was used to calculate the pharmacokinetic parameters and assess bioequivalence of the 2 formulations. It is considered bioequivalent if the 90% CIs of the mean ratios (test: reference) for Cmax, AUC0-t and AUC0-∞ are all within the range from 80% to 125%.RESULTS:No period, formulation, or sequence effects were observed on any pharmacokinetic parameters. The main pharmacokinetic parameters for the test and reference were as follows: t1/2 were 1.412±0.168 h and 1.390±0.162 h; Tmax were 1.850±0.462 h and 1.800±0.571 h; Cmax were 4.035±1.055 μg · ml-1 and 3.858±0.986 μg · ml-1; AUC0-12 were 14.006±2.564 μg · ml-1 · h and 13.345±2.128 μg · ml-1 · h, and the AUC0-∞ were 14.147±2.568 μg · ml-1 · h and 13.486±2.117 μg · ml-1 · h. The 90% CIs for the ratios (test/reference) of Cmax, AUC0-12, and AUC0 - ∞ were 98.0-111.2%, 100.8-108.5%, and 100.8-108.3%, respectively.CONCLUSIONS:In this small study, a single 250-mg oral dose of an acipimox tablet (test formulation) is bioequivalent to the established reference formulation.

Pharmacokinetics and Bioequivalence of 2 Dosage Forms of Azithromycin Tablets in Healthy Volunteers

Bioequivalence of Azithromycin Tablets in Healthy Volunteers

Bioequivalence of Domestic Azithromycin Granules in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Pharmacokinetics and Relative Bioavailability of Azithromycin Tablets

Evaluation of quality consistency of enteric-coated capsule azithromycin with imported tablet of azithromycin

Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Pharmacokinetics and Bioequivalence of Two Powders of Azithromycin for Suspension: A Nonblinded, Single-Dose, Randomized, Three-Way Crossover Study in Fed and Fasting States Among Healthy Chinese Volunteers

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Bioequivalence of erythromycin ethylsuccinate orally disintegrating tablet in healthy volunteers

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Pharmacokinetics and Bioequivalence of 2 Kinds of Amoxicillin Dispersible Tablets in Healthy Volunteers

Pharmacokinetics and Bioequivalence Study of Cefixime Tablet in Healthy Volunteers

A Reference‐Scaled Average Bioequivalence Study of Azithromycin Tablets Manufactured in China and the United States: An Open‐Label, Randomized, Single‐Dose, 3‐Way Crossover Study in Healthy Chinese Subjects Under Fasted and Fed Conditions

Bioequivalence of erythromycin enteric-coated capsules in healthy volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Quantitative determination of azithromycin in human plasma by liquid chromatography-mass spectrometry and its application in a bioequivalence study.

Pharmacokinetic and Bioequivalence Evaluation of Two Cefprozil Dispersible Tablets in Healthy Chinese Volunteers

Pharmacokinetics and Bioequivalence Evaluation of Two Acipimox Tablets: A Single-Dose, Randomized-Sequence, Two-Way Crossover Study in Healthy Chinese Male Volunteers

Bioequivalence Study of Two Esomeprazole Enteric Coated Formulations in Healthy Chinese Volunteers